MMMelissa de Oliveira Melchior

Melissa de Oliveira Melchior

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melissa de Oliveira Melchior has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Mindfulness-based orofacial pain education promotes perceived control and self-management in painful TMD

    by Beatriz Dorne, Giovana Quaresma Del Grande, Alex Moreira Mélo, Paula Rodrigues-Pereira, Melissa Oliveira Melchior, Matheus Herreira-Ferreira, Jardel Francisco Mazzi-Chaves, Laís Valencise Magri

  • Sexual function in women with chronic painful temporomandibular disorders: A biopsychosocial case–control study

    by Maria Amália Pereira Dias-Calças, Lívia Prado Remédio, Victor Hugo Alves Ribeiro-Silva, Laiz Franco, Larissa Gregório Candido-Do-Prado, Giovanna Gallo, Alex Moreira Mélo, Melissa de Oliveira Melchior, Lúcia Alves da Silva Lara, Christie Ramos Andrade Leite-Panissi, et al.

  • Open Access

    Inflammatory, oxidative, and neurotrophic profiles in monozygotic twins discordant for pain-related TMD

    by Laís Valencise Magri, Melissa Oliveira Melchior, Cecília Nogueira Tavares Peixeiro, Vitória Carolina Rondon-Pereira, Margarete Ribeiro-Dasilva, Kranya Victoria Díaz-Serrano, Riccardo Lacchini, Edilaine Cristina da Silva Gherardi-Donato, Christie Ramos Andrade Leite-Panissi

    This study investigated the biological mechanisms underlying temporomandibular disorder (TMD) pain in monozygotic twins discordant for the condition, isolating environmental factors from genetic influence. Twenty women (ten pairs of discordant twins) underwent standardized examinations and venous plasma analysis. Inflammatory biomarkers (IL-6, IL-10), oxidative markers (MDA, SOD, catalase), matrix remodeling proteins (MMP-2, MMP-9, TIMP-1, TIMP-2), and neurotrophic factors (BDNF, β-NGF, α2M) were measured. Twins with painful TMD demonstrated greater pain severity, functional interference, and mechanical sensitivity compared to discordant controls. Significant within-pair differences were identified in IL-6, IL-6/IL-10 ratio, MDA/SOD ratio, MMP-9, TIMP-2, and BDNF levels. Pro-inflammatory and oxidative indices positively correlated with pain intensity and palpation sensitivity, while reduced BDNF associated with greater symptom burden. Principal component analysis revealed a dominant inflammatory-oxidative profile that discriminated painful twins from controls. In genetically identical individuals, painful TMD associates with selective peripheral biological alterations involving inflammation, oxidative imbalance, and extracellular matrix remodeling. These findings could demonstrate that environmental and experiential factors biologically may contribute to vulnerability to chronic orofacial pain, highlighting the importance of epigenetic mechanisms in TMD pathogenesis beyond genetic predisposition. This article identifies specific peripheral biomarker profiles distinguishing monozygotic twins with and without painful TMD, and could show that inflammation, oxidative imbalance, matrix remodeling, and reduced neurotrophic support characterize the painful phenotype. These mechanistic insights could enable clinicians to develop targeted, biologically informed therapeutic strategies and potentially predict pain vulnerability in genetically susceptible individuals.

  • Open Access

    Epigenetic and biomolecular mechanisms in chronic temporomandibular disorder–related pain: an integrative review

    by Laís Valencise Magri, Melissa de Oliveira Melchior, Victor Hugo Alves Ribeiro-Silva, Jardel Francisco Mazzi-Chaves, Kranya Victoria Díaz-Serrano, Edilaine Cristina Silva Gherardi-Donato, Christie Ramos Andrade Leite-Panissi

    Temporomandibular disorders (TMD) are multifactorial chronic pain conditions involving the temporomandibular joint, masticatory muscles, and associated structures, with a marked predominance in women. Despite their high prevalence and significant impact on quality of life, the biological mechanisms underlying pain chronification in TMD remain incompletely understood. Growing evidence indicates that persistent TMD-related pain arises from complex interactions among inflammatory signaling, oxidative stress, neuroendocrine dysregulation, and epigenetic modulation of gene expression. This integrative narrative review synthesizes current clinical and preclinical evidence from molecular biology, neuroendocrinology, and epigenetics to elucidate the biomolecular mechanisms involved in chronic TMD pain. Studies consistently report elevated proinflammatory cytokines, such as interleukin-6 and tumor necrosis factor-α, alongside increased oxidative stress markers, including malondialdehyde and 8-hydroxy-2′-deoxyguanosine, accompanied by reduced antioxidant capacity in saliva and serum. Alterations in neuroendocrine mediators, particularly dysregulation of the hypothalamic–pituitary–adrenal axis and reduced levels of neurotrophic factors such as brain-derived neurotrophic factor and nerve growth factor, appear to contribute to central sensitization and impaired neuroplasticity. In parallel, epigenetic mechanisms—including DNA methylation of pain- and stress-related genes (e.g., COMT and TNFα ) and differential expression of microRNAs such as miR-140-5p and miR-21-5p—emerge as key modulators of pain susceptibility, persistence, and sex-related differences in clinical presentation. By integrating biomolecular, neuroendocrine, and epigenetic evidence, this review highlights biological signatures associated with chronic TMD pain and discusses their relevance for mechanistic understanding, biomarker discovery, and the development of biologically informed strategies for individualized pain management.


  • Open Access

    Cannabinoid Therapy for Refractory Trigeminal Neuropathic Pain: Quantification of Somatosensory Alterations (QualST) by 3D Stereophotogrammetry—Two Case Reports

    by Alex Moreira Mélo, Luiz Guilherme Spadon-Brito, Júia Carrer Hallak, Glauce Crivelaro Do Nascimento, Melissa de Oliveira Melchior, Simone Cecílio Hallak Regalo, Jardel Francisco Mazzi-Chaves, Laís Valencise Magri

    Background: Trigeminal neuropathic pain (TNP) is a chronic and debilitating condition frequently resistant to conventional pharmacological therapies. Although cannabinoids have emerged as a potential adjunctive treatment, objective clinical documentation of their effects in orofacial neuropathic pain remains limited. Case Reports: We report two female patients with refractory TNP—one post‐traumatic and one idiopathic—who experienced insufficient relief despite trials of anticonvulsants, antidepressants, topical agents, and local interventions. Both patients received a balanced tetrahydrocannabinol (THC):cannabidiol (CBD) sublingual formulation (20 mg/mL each) following a structured titration protocol and were monitored over 8 weeks. Outcomes were assessed using the Douleur Neuropathique 4 Questions (DN4), the visual analog scale (VAS), the World Health Organization Quality of Life‐BREF (WHOQOL‐Bref), and qualitative sensory testing (QualST). Additionally, three‐dimensional facial stereophotogrammetry was employed to objectively quantify areas of hyperfunction and allodynia. Treatment resulted in a marked analgesic response (VAS reduction from 9 to 4 and from 10 to 2), qualitative changes in pain phenotype—from shock‐like to predominantly burning—and functional improvement in mastication and oral hygiene. Stereophotogrammetry demonstrated a substantial reduction in sensitized regions, with extraoral hyperfunctional area decreasing from 113.72 to 27.54 cm 2 and complete resolution of allodynia by week 8. WHOQOL‐Bref scores improved in both patients, with physical domain scores increasing from 50.0 to 60.7 and from 25.0 to 39.3, accompanied by gains in psychological well‐being. No serious adverse events were recorded. Conclusion: These cases illustrate the potential clinical relevance of cannabinoids as an adjunctive approach for refractory TNP and highlight the importance of multidimensional assessment strategies. The findings should be interpreted cautiously given the descriptive nature of case reports; however, they underscore the need for controlled studies to further investigate the efficacy and safety of cannabinoid‐based therapies in orofacial neuropathic pain.


  • Open Access

    Mindfulness Level Influences the Frequency, Amplitude and Duration of Awake Bruxism Episodes During Standardised Mental Capacity Tasks

    by Rafael Chadud Matoso‐Filho, Caio Sberni Pinheiro Souza, Nykolas Jorge Silva Castaldi, Melissa Oliveira Melchior, Fabiane Carneiro Lopes‐Olhê, Simone Cecílio Hallak Regalo, Laís Valencise Magri, Jardel Francisco Mazzi‐Chaves

    Background: Awake bruxism ( AB ) is characterised by repetitive or sustained masticatory muscle activity during wakefulness, including clenching, grinding, or mandibular bracing. Recent consensus defines AB as a motor behaviour influenced by psychological and contextual factors. Among these, dispositional mindfulness may play a modulatory role in the frequency and intensity of AB episodes. Objective: This study aimed to evaluate how standardised cognitive tasks of varying complexity modulate awake bruxism ( AB ) and to investigate whether dispositional mindfulness is associated with the frequency, duration, and amplitude of AB episodes measured by surface electromyography. Methods: A cross‐sectional study was conducted with 68 dental students (18–40 years) from the School of Dentistry of Ribeirão Preto, University of São Paulo. Participants were classified into AB and control groups based on self‐report and Ecological Momentary Assessment ( EMA ). Surface electromyography ( sEMG ) of the masseter muscle was recorded during five conditions: rest, maximal voluntary clenching, self‐report questionnaires, mathematical tasks of different complexity, and an electronic memory game (Genius). Episodes were analysed at thresholds of 10%, 20%, and 30% of maximal voluntary contraction (Ap10, Ap20, Ap30), extracting frequency, duration, and amplitude. Dispositional mindfulness was assessed using the Five Facet Mindfulness Questionnaire ( FFMQ ). Statistical analyses included Friedman tests, Mann–Whitney U tests, Generalised Estimating Equations ( GEE ), and Spearman correlations. Results: Controls showed increased episode frequency at lower thresholds (Ap10) as task complexity rose, whereas AB individuals maintained elevated frequencies across all tasks. Significant between‐group differences were observed at higher thresholds (Ap20, Ap30). Duration and amplitude showed no significant differences, except for a trend of greater amplitude in controls during the Genius task. Within the AB group, higher dispositional mindfulness was associated with fewer and shorter contraction episodes, a pattern consistent with previous research indicating a potential protective association. (notably at Ap30) and shorter durations across tasks, while no associations were observed in controls. Conclusion: AB individuals exhibited a stable and persistent pattern of masticatory muscle activity, contrasting with the adaptive modulation observed in controls. Higher dispositional mindfulness was linked to fewer and shorter contraction episodes in the AB group, suggesting a protective role. These findings highlight the relevance of integrating psychological traits, such as mindfulness, into the behavioural understanding and management of AB.

  • Effectiveness of treatments for temporomandibular joint osteoarthritis: a systematic review and meta-analysis

    by Luiz Guilherme Spadon-Brito, Caio Sberni Pinheiro Souza, Alex Moreira Mélo, Maria Amália Dias Pereira Calças, Melissa Oliveira Melchior, Fernanda Leal Vieira, Fabiane Carneiro Lopes-Olhê, Joel Ferreira Santiago-Junior, Lais Valencise Magri, Jardel Francisco Mazzi-Chaves

    Objectives To evaluate the effectiveness of minimally invasive interventions (arthrocentesis and intra-articular injections) versus conservative therapies for temporomandibular joint osteoarthritis (TMJ OA). Methods This systematic review included randomized controlled and prospective or observational studies involving patients with TMJ OA. A comprehensive search of five databases was conducted up to November 2024. Pain intensity (VAS) and maximum mouth opening (MMO) were analyzed via meta-analysis, with risk of bias assessed using ROB 2 and ROBINS-I tools, and certainty of evidence using GRADE. The significance level adopted for the analysis was set at α = 0.05. Results Sixteen studies (901 patients) were included. Arthrocentesis, alone or with adjuvants such as PRP, i-PRF, corticosteroids, or NSAIDs, significantly improved pain (MD − 5.50; 95%CI: − 6.61 to − 4.39) and MMO (MD 6.97 mm; 95%CI: 1.96 to 11.98) versus baseline and between groups. Intra-articular hyaluronic acid, with or without glucosamine, showed clinical benefit over time, but its superiority over conservative care was inconsistent. Substantial heterogeneity was observed, mainly in injection-based protocols. GRADE indicated high certainty of evidence for most comparisons, except one (MMO, moderate certainty). Conclusions Minimally invasive therapies, especially arthrocentesis with biological adjuvants, seems to be effective for TMJ OA management. However, due to heterogeneity and methodological limitations, their superiority over conservative strategies remains uncertain. Statement Clinical Relevance Minimally invasive therapies, particularly arthrocentesis with or without biological agents, may reduce pain and improve jaw function in TMJ OA, offering a potential alternative to conservative treatments over a 3- to 12-month period.


  • Open Access

    Impact of a Mindfulness‐Based Intervention on Pain and Psychological Factors in Women With Chronic Painful Temporomandibular Disorders

    by Melissa de Oliveira Melchior, Laís Valencise Magri, Kranya Victoria Díaz‐Serrano, Elton Brás Camargo Júnior, Felipe Fregni, Kevin Pacheco‐Barrios, Riccardo Lacchini, Christie Ramos Andrade Leite‐Panissi, Edilaine Cristina Silva Gherardi‐Donato

    Background: Psychosocial factors influence the perception of TMD signs and symptoms. Regular mindfulness practice supports their management through emotional and cognitive self‐regulation, modulating the TMD‐related pain experience. Objective: To analyse the influence of a mindfulness‐based intervention on pain, cognitions, behaviour and emotions reported by women with TMD‐related chronic pain. Methods: Eighty‐four women, aged between 18 and 61 years, with chronic TMD (diagnosed according to the Diagnostic Criteria for Temporomandibular Disorders, DC/TMD), were randomised into an intervention group (IG) or a control group (CG). The intervention group underwent an 8‐week mindfulness practice programme, consisting of weekly 2‐h sessions and one immersion session lasting 4 h. The entire programme consisted of nine meetings. The control group did not receive any intervention during the same period. All participants underwent clinical pain assessments and completed self‐administered questionnaires before and after the intervention period. These questionnaires addressed cognitive, behavioural and emotional variables. Evaluators were blinded to the group allocations of the participants. Simple linear regression was used for the main statistical analyses, with significance established at p < 0.05. Results: Fifty‐three women completed the study (IG = 30; CG = 23). The intervention had a positive influence on the following variables: number of pain points, pain pressure threshold (PPT), stress, catastrophic thoughts and facets of mindfulness, including ‘observe’, ‘distract’, ‘non‐react’ and overall mindfulness levels (all analyses at p < 0.05). Conclusion: This unique trial, in which the mindfulness‐based intervention was compared against a control (no treatment), showed that mindfulness can contribute to the sensory, cognitive, behavioural and emotional management of pain‐related TMD. The improvement in pain, therefore, was probably influenced by the regulation of psychological aspects related to it.


  • Open Access

    Oral Health and Sociodemographic Aspects in Transgender People: A Descriptive Exploratory Study

    by Alex Moreira Mélo, Melissa de Oliveira Melchior, Fabiane Carneiro Lopes‐Olhê, Júlia Kefalás Troncon, Manoel Damião Sousa‐Neto, Laís Valencise Magri, Lúcia Alves da Silva Lara, Jardel Francisco Mazzi‐Chaves

    Objectives: This study evaluated the oral health condition of transgender (trans) men and women before starting gender‐affirming hormone therapy (GAHT), focusing on the prevalence of periodontal disease and temporomandibular disorder (TMD) as well as the influence of alcohol consumption and anxiety. Materials and Methods: The study was a cross‐sectional, descriptive exploratory study conducted with transgender individuals over the age of 18 from the Gender Incongruence Clinic (AING) at Ribeirão Preto Medical School (FMRP‐USP). The study was approved by the Research Ethics Committee of the School of Dentistry of Ribeirão Preto, University of São Paulo (FORP/USP) (CAAE No. 02198018.5.0000.5419) and the Research Ethics Committee on Human Beings of the Ribeirão Preto Medical School (HCRP/FMRP) (CAAE No. 59992522.1.3001.5440). All volunteers provided informed consent before participation. Inclusion criteria consisted of individuals over 18 years of age, patients of the AING, who were hormone‐free or had not used hormones for at least 6 months (for trans women), and those with no prior hormone use (for trans men). Exclusion criteria included individuals with cognitive limitations that could hinder comprehension of the research instruments, those who had used analgesics, non‐steroidal anti‐inflammatory drugs (NSAIDs) or opioids within 24 h before the assessments, and individuals with reports of head and neck trauma, a history of plastic surgeries or orofacial harmonisation procedures or those undergoing orthodontic treatment or extensive oral rehabilitation. Each participant completed a sociodemographic questionnaire and was assessed for periodontal health using the Periodontal Screening Recording (PSR), TMD using DC/TMD criteria and anxiety levels with the GAD‐7 scale. Data analysis included descriptive statistics, chi‐squared, T ‐test ( p < 0.05) and multivariate logistic regression. Results: A total of 54 trans individuals over the age of 18 from the Gender Incongruence Clinic (AING) at Ribeirão Preto Medical School (FMRP‐USP) were invited, with 45 participants completing the study (24 trans men, 21 trans women). High levels of gingivitis and plaque accumulation were found in all participants, with no significant gender differences ( p > 0.05). TMD was present in 83.33% of trans men and 47.62% of trans women, with a significantly higher incidence among trans men ( p = 0.046). Alcohol consumption ( p = 0.049) and anxiety ( p = 0.043) were significantly associated with TMD, especially among trans men 1.624 [Confidence Interval (95% CI): 1.006–2.621]. Conclusions: The study revealed alarming levels of gingivitis across all participants, highlighting the need for periodontal intervention. Over half of the participants exhibited TMD, with trans men showing a higher occurrence. TMD was significantly associated with alcohol consumption and anxiety. Clinical Relevance: The findings emphasise the need for integrated dental and mental health care in transgender populations, particularly for the prevention and management of TMD and periodontal disease.


  • Higher Levels of Dispositional Mindfulness Are Associated With More Effective Ecological Momentary Intervention Outcomes in Reducing the Frequency of Awake Bruxism Behaviours

    by Letícia Prado‐E‐Silva, Melissa de Oliveira Melchior, Alex Moreira Mélo, Juliana Stuginski‐Barbosa, Jardel Francisco Mazzi‐Chaves, Kranya Victoria Díaz‐Serrano, Edilaine Cristina da Silva Gherardi‐Donato, Christie Ramos Andrade Leite‐Panissi, Laís Valencise Magri

    Background: Previous research has highlighted the multifactorial nature of awake bruxism (AB), including its associations with stress, anxiety and other psychological factors. Dispositional mindfulness, known for its benefits in enhancing emotional regulation and reducing stress, has not yet been thoroughly investigated in association with AB. Objective: This study aimed to investigate whether levels of dispositional mindfulness predict the efficacy of ecological momentary intervention (EMI) in reducing the frequency of AB behaviours. Methods: This study employed a quasi‐experimental design with a correlational component and involved 83 undergraduate dental students categorised into high and low mindfulness groups based on the Mindfulness Attention and Awareness Scale (MAAS). An EMI was implemented using the No Clenching mobile app, which sent 12 alerts per day over 1 month. The primary outcome measure was a 50% reduction in the frequency of AB behaviours. Results: A significant positive relationship was found between dispositional mindfulness levels and the reduction in AB behaviours. Participants with higher mindfulness levels experienced a greater reduction in AB frequency compared to those with lower mindfulness levels. Mixed‐effects regression analysis revealed that mindfulness levels were a significant predictor of bruxism reduction ( β = 0.45, p < 0.01). The coefficient for MAAS was positive and significant (coefficient = 1.5305, p < 0.001), indicating that higher mindfulness levels are associated with greater reductions in AB frequency. Additionally, a significantly higher percentage of participants in the high mindfulness group (97.5%) achieved a 50% reduction in AB behaviours compared to the low mindfulness group (62%). Conclusion: Higher levels of dispositional mindfulness are associated with more effective EMI outcomes in reducing AB behaviours. Incorporating mindfulness‐based approaches into intervention strategies for AB could lead to more personalised and effective treatments.